Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Orr, H. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Orr, H. T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, 2002, Vol. 11, No. 17 1909-1910
© 2002 Oxford University Press

Microarrays and polyglutamine disorders: reports from the Hereditary Disease Array Group

Harry T. Orr*,{dagger}

Institute of Human Genetics, University of Minnesota, Minneapolis, MN 55455, USA

The first 10% of the full text of this article appears below.


   ARTICLE
 
Advances in molecular biology and genetics have allowed researchers to probe function and dysfunction at the level of the individual gene and/or protein. The integration of such information into an understanding of function has been a challenge facing all molecular geneticists and has contributed to the widening gap between molecular and systems scientists. In the neurosciences, this rift is especially dramatic. The ability to simultaneously monitor changes in the expression of thousands of genes using DNA microarrays has the potential to provide a global or ‘genomic’ view of brain function/dysfunction.

Two important barriers in the application of this technology to the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum Mol GenetHome page
A. Hodges, A. D. Strand, A. K. Aragaki, A. Kuhn, T. Sengstag, G. Hughes, L. A. Elliston, C. Hartog, D. R. Goldstein, D. Thu, et al.
Regional and cellular gene expression changes in human Huntington's disease brain
Hum. Mol. Genet., March 15, 2006; 15(6): 965 - 977.
[Abstract] [Full Text] [PDF]

Home page
 Sci Aging Knowl EnvironHome page
B. S. Kristal and Y. I. Shurubor
Metabolomics: Opening Another Window into Aging
Sci. Aging Knowl. Environ., June 29, 2005; 2005(26): pe19 - pe19.
[Abstract] [Full Text]

Home page
 Proc. Natl. Acad. Sci. USAHome page
S. Holbert, A. Dedeoglu, S. Humbert, F. Saudou, R. J. Ferrante, and C. Neri
Cdc42-interacting protein 4 binds to huntingtin: Neuropathologic and biological evidence for a role in Huntington's disease
PNAS, March 4, 2003; 100(5): 2712 - 2717.
[Abstract] [Full Text] [PDF]